本网站使用我们的 cookie Cookie 政策. 要查看我们提供的 cookie，请查看我们的 Cookie 设置面板. 我同意此 cookie 政策，不再显示此消息

Event on

Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease

演示文稿

  • PROF. GOTTFRIED RUDOFSKY

    PROF. GOTTFRIED RUDOFSKY
    (SWITZERLAND)
    Speaker

    Specialist in Internal Medicine – Endocrinology and Diabetology, Nephrology. Head of private practice in the fields of internal medicine and endocrinology, Olten, Switzerland

所提出的观点和意见仅代表作者。 此网络广播中包含的内容仅供参考/教育目的。

背景

Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether1 — which is why testing in at-risk groups is so important.

Join this livestream series of 20 minutes each to learn how early detection can slow disease progression or even prevent it valtogether.

Our international speakers will discuss the role of rapid diagnostics in disease prevention, with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.

Learn more about current guidelines and kidney disease prevention and management.

Series of six livestream events covering:

  • Importance of regular testing for early detection and monitoring in high-risk patients
  • Importance of ACR testing beside the determination of eGFR
  • Latest guidance on disease prevention and management
  • Case studies
Share
Like
Tweet
References
  1. Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
  2. The International Society of Nephrology (ISN). Chronic Kidney Disease: HYPERLINK https://www.worldkidneyday.org/facts/chronic-kidney-disease.%20Accessed%201.%20September%202022 https://www.worldkidneyday.org/facts/chronic-kidney-disease. Accessed 1. September 2022

© 2023 年雅培。版权所有。引用的所有商标均为雅培集团公司或其各自所有者的商标。 COL-00000

"-- SEO4AJAX --" "seo4ajax Access"

"-- SEO4AJAX --" "Init" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"zh","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"}

"-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"zh","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/zh/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"zh","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/zh/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Timeout: " 5 " seconds"

"-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mypocacademy/ww/zh/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Bugsnag Called"